ABATE KRISTIN (Chief Accounting Officer) sold 2.5% of their position (559.00 shares) of KARYOPHARM THERAPEUTICS INC. on the open market
Open‑market sale worth $5.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/3/2026ACC: 0002045943-26-000003
Officer· Chief Accounting Officer
Since Mar 2026
-559.00
Net shares
Net seller
$5.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
559.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−559.00
Price / share
$9.41
Trade value
$5.26K
% of position
2.5%
3/2/2026
22.62K→22.06K
Total
Net shares
−559.00
Net value
-$5.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | S · Sale | −559.00 | $9.41 | $5.26K | 2.5% | 22.62K | 22.06K |
| Total | −559.00 | -$5.26K | ||||||
Derivative Transactions0
No derivative transactions reported